This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Whole Grains for Diabetics, Heart Health

News

TORONTO—Researchers at St. Michael's Hospital, Toronto, assessed whether Salba (Salvia Hispanica L.) whole grain reduced postprandial glycemia in healthy subjects, as a possible explanation for its cardioprotective effects observed in individuals with diabetes (Eu J Clin Nutr.2010;64:436–438). The acute, randomized, double blind, controlled design administered 0, 7, 15 or 24 g of Salba baked into white bread to 11 healthy individuals. A dose-response reduction in postprandial glycemia was observed with all three doses of Salba, significantly decreasing incremental areas under the curve (iAUCs) and time point-specific blood glucose (P<0.05). Appetite ratings were decreased at 60 minutes after high, 90 minutes after high and intermediate and at 120 minutes after all treatments (P<0.05). Researchers stated the decrease in postprandial glycemia provided a potential explanation for improvements in blood pressure, coagulation and inflammatory markers previously observed after 12-week Salba supplementation in type 2 diabetes.

 

     

comments powered by Disqus